Erythrasma cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Irfan Dotani (talk | contribs) Created page with "__NOTOC__ {{Erythrasma}} {{CMG}}; {{AE}} {{PleaseHelp}} ==Overview== ==Cost-Effectiveness of Therapy== ==References== {{Reflist|2}} Category:Disease Category:Dermat..." |
m Bot: Removing from Primary care |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 11: | Line 11: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WS}} | |||
{{WH}} | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Emergency medicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
Latest revision as of 21:39, 29 July 2020
|
Erythrasma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Erythrasma cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Erythrasma cost-effectiveness of therapy |
|
Risk calculators and risk factors for Erythrasma cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.